Cydar Medical secures £82.7k for AI-driven surgical software

AI-driven surgical software developer Cydar Limited has secured an estimated £82.7k in new funding. The Cambridge-based company, which operates as Cydar Medical, filed the allotment on 2026-05-06 following an allotment date of 2026-04-01.

Incorporated on 2012-03-12, Cydar Medical creates technology to assist clinicians during minimally invasive procedures. Its primary offering, Cydar EV Maps, uses cloud-based AI and computer vision to provide 3D surgical planning and intra-operative navigation. The software is designed to improve surgical accuracy and support decision-making for clinical teams, specifically in endovascular aortic repair. The company has stated plans to expand its technology into other medical fields, including orthopaedics and cancer treatment.

The latest accounts for the business show a headcount of 39 employees. LinkedIn data lists 38 staff members and identifies the company's core specialties as medical software, data fusion, and vascular surgery. Cydar Medical aims to reduce the cost of care for hospitals by using data-driven insights to improve patient outcomes and streamline surgical workflows.

This £82.7k round follows a high frequency of share allotments recorded throughout the previous year. Between June and September 2025, Cydar Limited completed ten separate funding rounds. The largest of these was a £451.4k raise on 2025-06-27, followed by a £150k allotment on 2025-08-26. Other raises in that period included £84.1k on 2025-08-27 and £64.5k on 2025-08-29. Several smaller allotments were also filed, such as a £12.4k raise on 2025-09-02 and a £15.9k raise on 2025-08-28.

The company continues to operate from its headquarters in Cambridge, focusing on the development of its end-to-end solution for image-guided surgery.